KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to -$10.0 million.

  • Dynavax Technologies' Change in Accured Expenses fell 37779.63% to -$10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $501000.0, marking a year-over-year decrease of 9596.68%. This contributed to the annual value of $11.0 million for FY2024, which is 4430.31% down from last year.
  • Dynavax Technologies' Change in Accured Expenses amounted to -$10.0 million in Q3 2025, which was down 37779.63% from $10.8 million recorded in Q2 2025.
  • Dynavax Technologies' Change in Accured Expenses' 5-year high stood at $62.3 million during Q3 2021, with a 5-year trough of -$39.6 million in Q1 2022.
  • For the 5-year period, Dynavax Technologies' Change in Accured Expenses averaged around $2.1 million, with its median value being $3.6 million (2024).
  • As far as peak fluctuations go, Dynavax Technologies' Change in Accured Expenses skyrocketed by 274289.54% in 2021, and later tumbled by 129055.15% in 2022.
  • Over the past 5 years, Dynavax Technologies' Change in Accured Expenses (Quarter) stood at -$30.4 million in 2021, then surged by 81.08% to -$5.7 million in 2022, then skyrocketed by 247.15% to $8.5 million in 2023, then fell by 16.43% to $7.1 million in 2024, then crashed by 241.32% to -$10.0 million in 2025.
  • Its Change in Accured Expenses was -$10.0 million in Q3 2025, compared to $10.8 million in Q2 2025 and -$7.4 million in Q1 2025.